Euphrates Vascular - Crunchbase Company Profile & Funding

Q: Who invested in Euphrates Vascular?

Euphrates Vascular has 8 investors including Cultivation Capital And +ND Capital.

Q: How much funding has Euphrates Vascular raised to date?

Euphrates Vascular has raised obfuscated.

Overview

Euphrates Vascular

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Euphrates Vascular

CB Rank

75391

Euphrates Vascular develops medical devices that treat vascular occlusions related to vascular disease.

Founded

obfuscation

Private

Venture - Series Unknown

St Louis, Missouri, United States

1-10

euphratesvascular.com

Biotechnology

Health Care

Health Diagnostics

Medical Device

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Debt Financing

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Sean Morris: Chief Executive Officer & Board Member
Past Role: Veniti, Founder
Troy Long: President and CMO

Details

Legal Name

Euphrates Vascular, Inc.

Also Known As

Pulse Therapeutics

Operating Status

Active

Company Type

For Profit

Founders

Francis Creighton, Rogers Ritter, Rogers Ritter

About the Company

Euphrates Vascular develops medical devices that treat vascular occlusions related to vascular disease. Euphrates Vascular's Magnetically-Enhanced Diffusion system uses patented magnet-based technology to transport iron-oxide MED MicroBeads and clot-busting drugs at a much faster rate than otherwise possible, enabling doctors to improve care

for stroke and other diseases.

Euphrates Vascular was created through the merger of Pulse Therapeutics and ICHOR Vascular.

Phone Number

314-787-7475

Contact Email

admin@pulsetherapeutics.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Pulse NanoMED™ System

A system designed to assist in the delivery of therapeutics for restoring blood flow in cases of acute ischemic stroke, ST-elevation myocardial infarction, and peripheral arterial disease.

Pulse NanoMED System

A nanoscale interventional medical device designed to diagnose and treat vascular occlusions unreachable by traditional wires and catheters using iron-oxide nanoparticles controlled by an external rotating magnet.

Research & Development

Euphrates Vascular is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Euphrates Vascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Euphrates Vascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Euphrates Vascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Euphrates Vascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Euphrates Vascular	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Euphrates Vascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Euphrates Vascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Euphrates Vascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Euphrates Vascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Euphrates Vascular	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Cultivation Capital	No	Venture Round - Euphrates Vascular	Cliff Holekamp, William Schmidt
Cultivation Capital	No	Venture Round - Euphrates Vascular	Cliff Holekamp, William Schmidt
Cultivation Capital	No	Venture Round - Euphrates Vascular	Cliff Holekamp, William Schmidt
Cultivation Capital	No	Venture Round - Euphrates Vascular	Cliff Holekamp, William Schmidt
Cultivation Capital	No	Venture Round - Euphrates Vascular	Cliff Holekamp, William Schmidt